Results 231 to 240 of about 35,564,507 (249)
Some of the next articles are maybe not open access.

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet. Infectious Diseases (Print)
Summary Background Molnupiravir and nirmatrelvir–ritonavir are oral antivirals that have shown efficacy in preventing disease progression in outpatients with COVID-19.
O. Abani   +499 more
semanticscholar   +1 more source

Time series electrocardiography (ECG) data for early prediction of cardiac arrest

Scientific Reports
Artificial intelligence is revolutionizing modern healthcare by enabling more precise and predictive diagnostics. In cardiology, AI is playing a vital role by assisting medical practitioners in analyzing complex electrocardiography (ECG) patterns with ...
M. Umair   +6 more
semanticscholar   +1 more source

Machine learning guided process optimization and sustainable valorization of coconut biochar filled PLA biocomposites

Scientific Reports
This study focuses on the valorization of coconut shell biochar (CCB) as a sustainable reinforcement in polylactic acid (PLA) biocomposites, targeting enhanced mechanical performance.
Harishbabu Sundarasetty   +5 more
semanticscholar   +1 more source

Resources

IT Professional Magazine, 1998
E. Zintel
semanticscholar   +1 more source

Automated heart disease detection using Swin Transformer and ECG signal processing: a high-accuracy approach

Scientific Reports
Cardiovascular diseases (CVDs) are a leading cause of global mortality, necessitating early and accurate detection to improve patient outcomes. Electrocardiography (ECG) is a fundamental diagnostic tool for identifying cardiac abnormalities; however ...
Muhammad Faisal Abrar   +6 more
semanticscholar   +1 more source

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet. Infectious Diseases (Print)
Summary Background Sotrovimab is a neutralising monoclonal antibody targeting the SARS-CoV-2 spike protein. We aimed to evaluate the efficacy and safety of sotrovimab in the RECOVERY trial, an investigator-initiated, individually randomised, controlled ...
O. Abani   +499 more
semanticscholar   +1 more source

Information Technology (IT)

Accelerating Global Supply Chains with IT-Innovation, 2011
Z. Baida   +3 more
semanticscholar   +1 more source

Understanding Web 2.0

IT Professional, 2007
S. Murugesan
semanticscholar   +1 more source

Retinoic acid embryopathy.

New England Journal of Medicine, 1985
Lammer Ej   +9 more
semanticscholar   +1 more source

Progression

Making it as a Teacher, 2019
Victoria Hewett
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy